DENTSPLY regulatory

Aug. 19, 2011
Approval received from the relevant national competition authorities to proceed with the acquisition of the shares of Astra Tech AB, a leading provider of dental implant and urology products.

YORK, Pennsylvania--DENTSPLY International, a leader in professional dental products, has announced receipt of regulatory approval from the relevant national competition authorities to proceed with the acquisition of the shares of Astra Tech AB.

Astra Tech AB is a leading provider of dental implant and urology products from AstraZeneca.

The previously announced transaction is now expected to close Aug. 31, 2011.

DENTSPLY International to acquire Astra Tech from AstraZeneca

For more information, go to www.dentsply.com.

To comment on this topic, go to community.pennwelldentalgroup.com/.